Physician

Matthew Amiebi Daka, M.D

According to 2025 Medicare claims, Matthew Daka, M.D (NPI: 1598985715) practices cardiology in the Fayetteville, NC market, with the plurality of this provider's patient population coming from Cumberland, NC. This provider's primary affiliated billing organization is FERNCREEK CARDIOLOGY PA (NPI: 1104144914; TIN: 272254659) and primary practice location at 28304-2139.

Daka's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 578 traditional Medicare patients, billed 4,564 HCPCS/CPT codes, and received $332,941 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 5,069 prescription claims across 546 beneficiaries totaling $805,022 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 18 claims. Open Payments data shows 36 records totaling $800. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $1,083,353 to $332,941. In contrast, Part D prescription costs have moved sharply higher in recent years, from $201,695 to $805,022. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $5,298 and ending at $39,044.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,234	6,474	$1,083,353
2016	1,283	6,623	$1,184,081
2017	1,338	6,654	$907,499
2018	1,148	5,502	$741,233
2019	1,055	5,415	$733,337
2020	852	5,231	$689,319
2021	715	4,453	$533,737
2022	645	3,855	$411,099
2023	596	4,088	$343,027
2024	578	4,564	$332,941

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	350	3,006	$201,695
2016	357	3,253	$251,409
2017	371	3,384	$263,654
2018	385	3,660	$282,830
2019	386	3,645	$341,261
2020	387	3,772	$427,569
2021	442	3,820	$477,391
2022	473	4,222	$627,304
2023	508	4,777	$753,379
2024	546	5,069	$805,022

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$1,627
2016	N/R	N/R	N/R
2017	N/R	35	$60,787
2018	N/R	26	$44,854
2019	N/R	11	$22,645
2020	N/R	20	$38,253
2021	N/R	N/R	N/R
2022	N/R	18	$38,911
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	102	102	$301
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	228	231	$116
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	414	847	$91
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	356	572	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	359	418	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	342	18,534	$357,269
Entresto	Sacubitril/Valsartan	101	5,300	$118,887
Xarelto	Rivaroxaban	104	4,620	$84,724
Jardiance	Empagliflozin	78	3,766	$74,389
Ranolazine Er	Ranolazine	306	17,652	$30,171

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	36	$800	iRhythm Technologies, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew Amiebi Daka, M.D?

Tedicare shows public-source Medicare data for Matthew Amiebi Daka, M.D (NPI 1598985715), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Amiebi Daka, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Amiebi Daka, M.D?

Matthew Amiebi Daka, M.D is linked to FERNCREEK CARDIOLOGY PA (billing NPI 1104144914) in the available physician profile data.

Does Matthew Amiebi Daka, M.D have Open Payments data?

Matthew Amiebi Daka, M.D has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.